{"id":"W2133193675","doi":"10.1634/theoncologist.12-7-785","title":"First-Line Treatment Options for Patients with HER-2–Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy","year":2007,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"European Society for Medical Oncology; Pfizer","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Adjuvant; Oncology; Adjuvant therapy; Clinical trial; Quality of life (healthcare); Chemotherapy; Cancer; Randomized controlled trial; Internal medicine; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002184386,0.0005403591,0.001953226,0.00008811624,0.0001975165,0.00001089668,0.0002280953,0.0001230846,0.0003338782],"category_scores_gemma":[0.00001419338,0.0001911191,0.0008273913,0.0003029513,0.000478338,0.00002774597,0.00002594518,0.0002137891,0.000005876633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002165281,"about_ca_system_score_gemma":0.001137994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002118101,"about_ca_topic_score_gemma":0.001082456,"domain_scores_codex":[0.9984559,0.0001396966,0.0005110796,0.0003258197,0.0001920312,0.0003754077],"domain_scores_gemma":[0.9973818,0.001131259,0.0007146671,0.0004543749,0.000219204,0.00009866446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002200703,0.002955715,0.0002894151,0.001092002,0.005862131,0.000007664737,0.0003860976,0.0002045027,2.346837e-7,0.00001216976,0.001240329,0.985749],"study_design_scores_gemma":[0.03376902,0.03812722,0.007789719,0.005983018,0.04200523,0.0002197345,0.00008840701,0.0004629497,0.000009276451,0.000395876,0.8703015,0.0008480434],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001085118,0.98494,0.0001314499,0.001048039,0.0001544994,0.008474263,0.00387188,0.00003356528,0.0002612183],"genre_scores_gemma":[0.003403143,0.9919574,0.0002561926,0.0001079028,0.000281781,0.002372851,0.000402886,0.00007095688,0.001146856],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.984901,"threshold_uncertainty_score":0.779361,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1131886795486073,"score_gpt":0.466774363464914,"score_spread":0.3535856839163067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}